The success of Malaysia’s vaccination programme was built not in silos, but on powerful public-private partnerships. To now exclude GPs from the MR campaign is to forget that hard-earned lesson.
MOH launches a nationwide MRSIA campaign for children aged 6-59 months to get a third measles-containing vaccine dose, as only 62% of districts achieved 95% MMR vaccine coverage in 2024. Under the NIP, the MMR vaccine is given at 9 and 12 months of age.
Thailand uses a popular virtual human named Ingma, a schoolgirl composite of 1.2 mil dengue fever patients, to raise awareness. Malaysia builds vaccine equity and access through NIP; MOH also plans measles supplementary immunisation activities for 2024.
Cases of vaccine-preventable childhood diseases in Malaysia spiked post-pandemic in 2022: pertussis (818%), diphtheria (80%), measles (63%). Paediatricians say even a small drop in vaccination rates disrupted herd immunity; cases may rise more this year.